Ex Parte Anderson et al - Page 16


                     Appeal No.  2006-0102                                                                       Page 16                       
                     Application No.  09/732,439                                                                                               
                     catalyzes the synthesis of the osmoprotectant proline (column 17, claim 5 and                                             
                     column 18, claim 14).”  The examiner reasons (id.), since Verma II discloses that                                         
                     the monocot plants are drought resistant, the Δ1-pyrroline-5-carboxylate                                                  
                     synthetase must be “expressed in an amount effective to confer tolerance or                                               
                     resistance to a reduction in water availability. . . .”  Verma II is not entitled to the                                  
                     benefit of the September 29, 1992 filing date of Verma I for subject matter that is                                       
                     disclosed in Verma II but not in Verma I.  Specifically, since Verma I does not                                           
                     disclose monocots transformed with Δ1-pyrroline-5-carboxylate synthetase,                                                 
                     Verma II does not receive the benefit of Verma I’s filing date for this subject                                           
                     matter.  Instead, the new subject matter disclosing transformed monocots                                                  
                     present in Verma II receives benefit of the June 29, 1994 filing date of Verma II,                                        
                     which is after the August 25, 1993 effective filing date of the instant invention.                                        
                             Therefore despite the examiner’s assertion (Answer, page 26) that the                                             
                     methodology used by Verma II to transform monocots is the same as that used                                               
                     by Verma I to transform dicots, there is no evidence on this record that Verma I                                          
                     or Verma II disclosed a monocot transformed with Δ1-pyrroline-5-carboxylate                                               
                     synthetase as of the August 25, 1993 effective filing date of the present                                                 
                     application.  “Under 35 U.S.C. § 102, every limitation of a claim must identically                                        
                     appear in a single prior art reference for it to anticipate the claim.”  Gechter v.                                       
                     Davidson, 116 F.3d 1454, 1457, 43 USPQ2d 1030, 1032 (Fed. Cir. 1997).                                                     
                     “Every element of the claimed invention must be literally present, arranged as in                                         
                     the claim.”  Richardson v. Suzuki Motor Co., Ltd., 868 F.2d 1226, 1236, 9                                                 
                     USPQ2d 1913, 1920 (Fed. Cir. 1989).                                                                                       







Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007